Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab -Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis
ConclusionsThis non-gemcitabine-based regimen resulted in higher response rates and better survival than what is commonly observed with therapy given at conventional dosing schedules. Low-dose continuous (metronomic therapy) cytotoxic chemotherapy combined with antiangiogenic therapy is safe and effective.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Avastin | Breast Cancer | Calcium | Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Pancreas | Pancreatic Cancer | Toxicology | Women